Ophthalmic Devices are those devices which are used for vision correction or in ophthalmic diagnostic interventions. A Corneal Implant is a naturally based or artificially engineered cornea that is implanted onto an eye of a patient to replace his or her damaged or diseased cornea. GlobalData uses proprietary data and analytics to provide a comprehensive report on the corneal implants market in France. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the corneal implants market in France was Sightlife followed by AJL Ophthalmic and Massachusetts Eye and Ear Infirmary.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Corneal Grafts, Keratoprostheses, and Intrastromal Corneal Rings are tracked under Corneal Implants. A Corneal Graft is a corneal tissue from a deceased or a healthy donor. A Keratoprostheses Device is an artificial cornea used to replace damaged cornea, mostly in cases of repeated failure of corneal transplantation using a corneal graft. Intrastromal Corneal Ring Segments (ICRS) are made of Polymethyl Methacrylate (PMMA) and are placed in the deep peripheral corneal stroma to flatten the cornea.
The corneal implants market in France can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size corneal implants in France, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
